Cytoreductive surgery for men with metastatic prostate cancer

about

Radium-223 for primary bone metastases in patients with hormone-sensitive prostate cancer after radical prostatectomy

P2860

Q41279824-C7C0A583-318D-4B42-8389-7FC0E30B0FC4

P2860

Cytoreductive surgery for men with metastatic prostate cancer

Item

http://www.wikidata.org/entity/Q38410261

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Cytoreductive surgery for men with metastatic prostate cancer

@en

type

Item

label

Cytoreductive surgery for men with metastatic prostate cancer

@en

prefLabel

Cytoreductive surgery for men with metastatic prostate cancer

@en

P1476

Cytoreductive surgery for men with metastatic prostate cancer

@en

P2093

Athos Katelaris

http://www.w3.org/2001/XMLSchema#string

Daniel Moon

http://www.w3.org/2001/XMLSchema#string

Nikolas Katelaris

http://www.w3.org/2001/XMLSchema#string

P2860

Current role of multiparametric magnetic resonance imaging in the management of prostate cancer

The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer.

Metastatic prostate cancer-does treatment of the primary tumor matter?

Radical prostatectomy in high-risk and locally advanced prostate cancer: Mayo Clinic perspective.

The results of treatment of prostate cancer bone metastases after CyberKnife radiosurgery.

Survival benefit of radical prostatectomy in lymph node-positive patients with prostate cancer.

Survival and quality of life of patients with stage D1 (T1-3 pN1-2 M0) prostate cancer. Radical prostatectomy plus androgen deprivation versus androgen deprivation alone.

Surgical management of lymph-node-positive prostate cancer: improves symptomatic control.

Role of radical prostatectomy in metastatic prostate cancer: data from the Munich Cancer Registry.

(68)Ga-PSMA PET/MR with multimodality image analysis for primary prostate cancer.

P304

103-106

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.PRNIL.2015.11.003

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Nathan Lawrentschuk

Declan G Murphy

P577

2015-12-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

287373727

http://www.w3.org/2001/XMLSchema#string

P698

27689067

http://www.w3.org/2001/XMLSchema#string

P932

5031896

http://www.w3.org/2001/XMLSchema#string

Cytoreductive surgery for men with metastatic prostate cancer

about

P2860

P2860

Cytoreductive surgery for men with metastatic prostate cancer

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932